acetazolamide has been researched along with Anterior Choroidal Artery Infarction in 45 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The cerebral blood flow and the P300 were measured before and 20 minutes after intravenous injection of 17 mg/kg acetazolamide in 15 cases of lacunar cerebral infarction and 10 healthy subjects." | 7.69 | [Cerebral blood flow increase and P300 latency prolongation by intravenous injection of acetazolamide--investigation in lacunar cerebral infarction and healthy subjects]. ( Hara, M; Mochizuki, Y; Oishi, M; Takasu, T, 1995) |
| "The aim of this study was to compare the effect of vasodilative stimuli for the measurement of cerebrovascular reactivity obtained by acetazolamide and hypercapnia in patients with chronic occlusive major cerebral artery disease." | 7.69 | Dissociation of vasoreactivity to acetazolamide and hypercapnia. Comparative study in patients with chronic occlusive major cerebral artery disease. ( Houkin, K; Ishikawa, T; Kazumata, K; Kuroda, S; Mitsumori, K; Tanaka, N, 1996) |
| "Prediction of cerebral infarction due to vasospasm (VS) following aneurysmal subarachnoid haemorrhage (SAH) was investigated using acetazolamide-activated (A-A) N-isopropyl-p-[123I]iodoamphetamine (123I-IMP) single photon emission computed tomography (SPECT) in 79 SAH patients." | 7.68 | Prediction of cerebral infarction due to vasospasm following aneurysmal subarachnoid haemorrhage using acetazolamide-activated 123I-IMP SPECT. ( Funakoshi, T; Kimura, T; Shinoda, J, 1993) |
| "CVR is impaired in alert patients with cerebral infarction, although the mean CBF is not reduced, and good collateral flow via the anterior communicating artery in patients with carotid occlusion may be a sign of well-preserved haemodynamic status." | 6.70 | Cerebrovascular reactivity to acetazolamide in alert patients with cerebral infarction: usefulness of first-pass radionuclide angiography using 99m Tc-HMPAO in monitoring cerebral haemodynamics. ( Chang, CC; Kanno, H; Kuwana, N; Yamamoto, I, 2001) |
| "Acetazolamide has been used for a long time for the evaluation of cerebral hemodynamics." | 5.35 | [Enlargement of cerebral infarction after CBF study with acetazolamide challenge: two case report]. ( Hirotsune, N; Meguro, T; Muraoka, K; Nishino, S; Tanabe, T; Terada, K, 2009) |
| " The cerebral blood flow (CBF), cerebral blood volume (CBV), cerebral oxygen extraction fraction (OEF), cerebral metabolic rate of oxygen (CMRO2), and vascular responses to hypercapnia and acetazolamide stress for CCD were measured in 20 patients with cerebrovascular disease by positron emission tomography with H2(15O), C15O, and 15O2." | 3.71 | Hemodynamic changes during neural deactivation in human brain: a positron emission tomography study of crossed cerebellar diaschisis. ( Hatazawa, J; Ito, H; Kanno, I; Okane, K; Shimosegawa, E; Tamura, H, 2002) |
| "We investigated the cerebral blood flow in mild to moderately hypertensive patients with chronic cerebral infarction before and after the administration of bunazosin hydrochloride sustained-release formulation, a selective sympathetic alpha1 receptor blocker." | 3.70 | Effects of bunazosin hydrochloride sustained-release formulation on cerebral circulation. ( Mochizuki, Y; Oishi, M; Takasu, T, 2000) |
| "The cerebral blood flow and the P300 were measured before and 20 minutes after intravenous injection of 17 mg/kg acetazolamide in 15 cases of lacunar cerebral infarction and 10 healthy subjects." | 3.69 | [Cerebral blood flow increase and P300 latency prolongation by intravenous injection of acetazolamide--investigation in lacunar cerebral infarction and healthy subjects]. ( Hara, M; Mochizuki, Y; Oishi, M; Takasu, T, 1995) |
| "The aim of this study was to compare the effect of vasodilative stimuli for the measurement of cerebrovascular reactivity obtained by acetazolamide and hypercapnia in patients with chronic occlusive major cerebral artery disease." | 3.69 | Dissociation of vasoreactivity to acetazolamide and hypercapnia. Comparative study in patients with chronic occlusive major cerebral artery disease. ( Houkin, K; Ishikawa, T; Kazumata, K; Kuroda, S; Mitsumori, K; Tanaka, N, 1996) |
| "Prediction of cerebral infarction due to vasospasm (VS) following aneurysmal subarachnoid haemorrhage (SAH) was investigated using acetazolamide-activated (A-A) N-isopropyl-p-[123I]iodoamphetamine (123I-IMP) single photon emission computed tomography (SPECT) in 79 SAH patients." | 3.68 | Prediction of cerebral infarction due to vasospasm following aneurysmal subarachnoid haemorrhage using acetazolamide-activated 123I-IMP SPECT. ( Funakoshi, T; Kimura, T; Shinoda, J, 1993) |
| "CVR is impaired in alert patients with cerebral infarction, although the mean CBF is not reduced, and good collateral flow via the anterior communicating artery in patients with carotid occlusion may be a sign of well-preserved haemodynamic status." | 2.70 | Cerebrovascular reactivity to acetazolamide in alert patients with cerebral infarction: usefulness of first-pass radionuclide angiography using 99m Tc-HMPAO in monitoring cerebral haemodynamics. ( Chang, CC; Kanno, H; Kuwana, N; Yamamoto, I, 2001) |
| "Transient ischemic attacks and cerebral infarction were the common symptoms in these patients." | 2.47 | Concurrent Graves' disease and intracranial arterial stenosis/occlusion: special considerations regarding the state of thyroid function, etiology, and treatment. ( Murakami, H; Nakagawa, T; Ohba, S, 2011) |
| "Silent cerebral infarcts (SCI) are common in patients with sickle cell disease (SCD) and are thought to be caused by a mismatch between oxygen delivery and consumption." | 1.72 | Assessment of functional shunting in patients with sickle cell disease. ( Afzali-Hashemi, L; Biemond, BJ; Mutsaerts, HJMM; Nederveen, AJ; Schrantee, A; Václavů, L; Wood, JC, 2022) |
| "We performed CAS to treat right internal carotid artery stenosis." | 1.56 | Effect of Unilateral Carotid Artery Stenting on Cognitive Function in Patients with Severe Bilateral Stenosis. ( Misaki, K; Miyashita, K; Nakada, M; Nakahara, M; Nakajima, R; Tsutsui, T; Uchiyama, N; Yoshikawa, A, 2020) |
| "Young patients with moyamoya disease frequently exhibit extensive cerebral infarction at the time of initial presentation, and even in the early postoperative period." | 1.36 | Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion. ( Fujimura, M; Hayashi, T; Shirane, R; Tominaga, T, 2010) |
| "Acetazolamide has been used for a long time for the evaluation of cerebral hemodynamics." | 1.35 | [Enlargement of cerebral infarction after CBF study with acetazolamide challenge: two case report]. ( Hirotsune, N; Meguro, T; Muraoka, K; Nishino, S; Tanabe, T; Terada, K, 2009) |
| "Subsequently, cerebral infarction occurred in the corresponding area." | 1.29 | Cerebral vasodilatory capacity mapping using technetium-99m-DTPA-HSA SPECT and acetazolamide in moyamoya disease. ( Honda, N; Inoue, Y; Machida, K; Momose, T; Tsutsumi, K, 1993) |
| "Acetazolamide challenge was not performed." | 1.29 | Persisting perfusion defect in transient ischemic attacks: a new clinically useful subgroup? ( De Coster, P; Jamart, J; Laloux, P; Laterre, C; Meurisse, H, 1996) |
| "Dipyridamole (0." | 1.29 | Brain SPECT with dipyridamole stress to evaluate cerebral blood flow reserve in carotid artery disease. ( Brannon, WL; Farrell, JJ; Hwang, TL; Saenz, A, 1996) |
| "At rest the patients with cerebral infarction, irrespective of whether ICa stenosis-occlusion was present or not, showed abnormal side-to-side CBF asymmetry." | 1.28 | CBF side-to-side asymmetries in stenosis-occlusion of internal carotid artery. Relevance of CT findings and collateral supply. ( Cavestri, R; D'Angelo, V; Ferrarini, F; Longhini, E; Nobili, F; Radice, L; Rodriguez, G; Sgorbati, C, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (4.44) | 18.7374 |
| 1990's | 26 (57.78) | 18.2507 |
| 2000's | 12 (26.67) | 29.6817 |
| 2010's | 3 (6.67) | 24.3611 |
| 2020's | 2 (4.44) | 2.80 |
| Authors | Studies |
|---|---|
| Afzali-Hashemi, L | 1 |
| Václavů, L | 1 |
| Wood, JC | 1 |
| Biemond, BJ | 1 |
| Nederveen, AJ | 1 |
| Mutsaerts, HJMM | 1 |
| Schrantee, A | 1 |
| Nakahara, M | 1 |
| Misaki, K | 1 |
| Tsutsui, T | 1 |
| Nakajima, R | 1 |
| Yoshikawa, A | 1 |
| Miyashita, K | 1 |
| Uchiyama, N | 1 |
| Nakada, M | 1 |
| He, MS | 1 |
| Sheu, MM | 1 |
| Huang, ZL | 1 |
| Tsai, CH | 1 |
| Tsai, RK | 1 |
| Suyama, K | 1 |
| Yoshida, K | 1 |
| Hayashi, K | 1 |
| Takahata, H | 1 |
| Yonekura, M | 1 |
| Nagata, I | 1 |
| Meguro, T | 1 |
| Tanabe, T | 1 |
| Muraoka, K | 1 |
| Terada, K | 1 |
| Hirotsune, N | 1 |
| Nishino, S | 1 |
| Hayashi, T | 1 |
| Shirane, R | 1 |
| Fujimura, M | 1 |
| Tominaga, T | 1 |
| Ohba, S | 1 |
| Nakagawa, T | 1 |
| Murakami, H | 1 |
| Pánczél, G | 1 |
| Bönöczk, P | 1 |
| Nagy, Z | 1 |
| Ito, H | 1 |
| Kanno, I | 1 |
| Shimosegawa, E | 1 |
| Tamura, H | 1 |
| Okane, K | 1 |
| Hatazawa, J | 1 |
| Yamauchi, H | 1 |
| Okazawa, H | 1 |
| Sugimoto, K | 1 |
| Kishibe, Y | 1 |
| Takahashi, M | 1 |
| Kuroda, S | 2 |
| Shiga, T | 1 |
| Ishikawa, T | 2 |
| Houkin, K | 2 |
| Narita, T | 1 |
| Katoh, C | 1 |
| Tamaki, N | 1 |
| Iwasaki, Y | 1 |
| Lane, M | 1 |
| McBride, J | 1 |
| Archer, J | 1 |
| Chen, A | 1 |
| Shyr, MH | 1 |
| Chen, TY | 1 |
| Lai, HY | 1 |
| Lin, CC | 1 |
| Yen, PS | 1 |
| Gur, AY | 1 |
| Gücüyener, D | 1 |
| Uzüner, N | 1 |
| Gilutz, Y | 1 |
| Ozdemir, G | 1 |
| Korczyn, AD | 1 |
| Bornstein, NM | 1 |
| Kuwabara, Y | 2 |
| Ichiya, Y | 2 |
| Sasaki, M | 2 |
| Yoshida, T | 2 |
| Masuda, K | 2 |
| Oishi, M | 7 |
| Mochizuki, Y | 7 |
| Hara, M | 2 |
| Takasu, T | 5 |
| Asenbaum, S | 1 |
| Reinprecht, A | 1 |
| Brücke, T | 1 |
| Wenger, S | 1 |
| Podreka, I | 1 |
| Deecke, L | 1 |
| Inoue, Y | 2 |
| Momose, T | 2 |
| Machida, K | 2 |
| Honda, N | 2 |
| Mamiya, T | 1 |
| Takahashi, T | 1 |
| Tsutsumi, K | 2 |
| Nariai, T | 1 |
| Suzuki, R | 1 |
| Hirakawa, K | 1 |
| Maehara, T | 1 |
| Ishii, K | 1 |
| Senda, M | 1 |
| Infeld, B | 1 |
| Davis, SM | 1 |
| Lichtenstein, M | 1 |
| Mitchell, PJ | 1 |
| Hopper, JL | 1 |
| Webster, MW | 1 |
| Makaroun, MS | 1 |
| Steed, DL | 1 |
| Smith, HA | 1 |
| Johnson, DW | 1 |
| Yonas, H | 1 |
| Kimura, T | 1 |
| Shinoda, J | 1 |
| Funakoshi, T | 1 |
| Sakashita, Y | 1 |
| Matsuda, H | 2 |
| Kakuda, K | 1 |
| Takamori, M | 1 |
| Tsuji, S | 1 |
| Shuke, N | 1 |
| Sumiya, H | 1 |
| Tonami, N | 1 |
| Hisada, K | 1 |
| Chamorro, A | 1 |
| Saiz, A | 1 |
| Vila, N | 1 |
| Ascaso, C | 1 |
| Blanc, R | 1 |
| Alday, M | 1 |
| Pujol, J | 1 |
| Laloux, P | 1 |
| Jamart, J | 1 |
| Meurisse, H | 1 |
| De Coster, P | 1 |
| Laterre, C | 1 |
| Akashi, Y | 1 |
| Fukumura, T | 1 |
| Hwang, TL | 1 |
| Saenz, A | 1 |
| Farrell, JJ | 1 |
| Brannon, WL | 1 |
| Kazumata, K | 1 |
| Tanaka, N | 1 |
| Mitsumori, K | 1 |
| Inao, S | 1 |
| Kuchiwaki, H | 1 |
| Yoshida, J | 1 |
| Furuse, M | 1 |
| Moriwaki, H | 1 |
| Matsumoto, M | 1 |
| Hashikawa, K | 1 |
| Oku, N | 1 |
| Ishida, M | 1 |
| Seike, Y | 1 |
| Watanabe, Y | 1 |
| Hougaku, H | 1 |
| Handa, N | 1 |
| Nishimura, T | 1 |
| Ohkubo, M | 1 |
| Odano, I | 1 |
| Noguchi, E | 1 |
| Ohtaki, H | 1 |
| Shibaki, M | 1 |
| Dobashi, Y | 1 |
| Yokoi, T | 1 |
| Molina, C | 1 |
| Sabín, JA | 1 |
| Montaner, J | 1 |
| Rovira, A | 1 |
| Abilleira, S | 1 |
| Codina, A | 1 |
| Shikata, E | 2 |
| Mizutani, T | 1 |
| Chang, CC | 1 |
| Kanno, H | 1 |
| Yamamoto, I | 1 |
| Kuwana, N | 1 |
| Cavestri, R | 1 |
| Radice, L | 1 |
| Ferrarini, F | 1 |
| Sgorbati, C | 1 |
| D'Angelo, V | 1 |
| Rodriguez, G | 1 |
| Nobili, F | 1 |
| Longhini, E | 1 |
| Mimura, H | 1 |
| Ono, S | 1 |
| Yanagimoto, S | 1 |
| Tomomitsu, T | 1 |
| Ikenaga, H | 1 |
| Muranaka, A | 1 |
| Morita, K | 1 |
| Nagai, K | 1 |
| Otsuka, N | 1 |
| Fukunaga, M | 1 |
| Raynaud, C | 1 |
| Rancurel, G | 1 |
| Tzourio, N | 1 |
| Soucy, JP | 1 |
| Baron, JC | 1 |
| Pappata, S | 1 |
| Cambon, H | 1 |
| Mazoyer, B | 1 |
| Lassen, NA | 1 |
| Cabanis, E | 1 |
| Vorstrup, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| C-arm Cone Beam CTA and CTP With Acetazolamide Challenge in Aneurysmal Subarachnoid Hemorrhage: Evaluating Predictability for Early Ischemia in Cerebral Vasospasm[NCT03377049] | Phase 4 | 11 participants (Actual) | Interventional | 2019-07-28 | Completed | ||
| The Role of Shear Stress in the Cerebrovascular Response to Acute Exercise[NCT03722953] | 18 participants (Actual) | Interventional | 2018-12-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Clinical neurological deterioration not attributable to other causes, mores specifically not due to re-bleeding, hydrocephalus, or metabolic changes. (NCT03377049)
Timeframe: Day 1-14 during the hospitalization
| Intervention | Participants (Count of Participants) |
|---|---|
| Acetazolamide Challenge | 2 |
Using perfusion map values, relative percent change will be calculated (NCT03377049)
Timeframe: pre and post perfusion during imaging procedure, up to an hour
| Intervention | percent change (Mean) |
|---|---|
| Acetazolamide Challenge | 19.785 |
Using perfusion map values, relative percent change will be calculated (NCT03377049)
Timeframe: pre and post perfusion during imaging procedure, up to an hour
| Intervention | percent change (Mean) |
|---|---|
| Acetazolamide Challenge | 21.659 |
The data that will be statistically compared is the pre-diamox perfusion in comparison to the post-diamox perfusion. A statistically significant change increase in CBF represents an appropriate response to Diamox. Lack of change in CBF or decrease in CBF could be suggestive of potential for developing vasospasm. (NCT03377049)
Timeframe: pre and post perfusion during imaging procedure, up to an hour
| Intervention | percent change (Mean) |
|---|---|
| Acetazolamide Challenge | 20.722 |
1 review available for acetazolamide and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Concurrent Graves' disease and intracranial arterial stenosis/occlusion: special considerations regarding the state of thyroid function, etiology, and treatment.
Topics: Acetazolamide; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Cerebral Angiography; Cerebral Infa | 2011 |
2 trials available for acetazolamide and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Reduced blood flow and preserved vasoreactivity characterize oxygen hypometabolism due to incomplete infarction in occlusive carotid artery diseases.
Topics: Acetazolamide; Aged; Arterial Occlusive Diseases; Brain; Cerebral Infarction; Cerebrovascular Circul | 2004 |
Cerebrovascular reactivity to acetazolamide in alert patients with cerebral infarction: usefulness of first-pass radionuclide angiography using 99m Tc-HMPAO in monitoring cerebral haemodynamics.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Carotid Stenosis; Cere | 2001 |
42 other studies available for acetazolamide and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Assessment of functional shunting in patients with sickle cell disease.
Topics: Acetazolamide; Adult; Anemia, Sickle Cell; Brain; Cerebral Infarction; Child; Humans; Magnetic Reson | 2022 |
Effect of Unilateral Carotid Artery Stenting on Cognitive Function in Patients with Severe Bilateral Stenosis.
Topics: Acetazolamide; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Carotid Artery, Internal; Carotid S | 2020 |
Sudden bilateral vision loss and brain infarction following cosmetic hyaluronic acid injection.
Topics: Acetazolamide; Antihypertensive Agents; Aspirin; Blindness; Cerebral Infarction; Cosmetic Techniques | 2013 |
Coexistence of Chiari 2 malformation and moyamoya syndrome in a 17-year-old girl.
Topics: Acetazolamide; Adolescent; Agenesis of Corpus Callosum; Anastomosis, Surgical; Arnold-Chiari Malform | 2009 |
[Enlargement of cerebral infarction after CBF study with acetazolamide challenge: two case report].
Topics: Acetazolamide; Aged; Cerebral Infarction; Cerebrovascular Circulation; Humans; Magnetic Resonance Im | 2009 |
Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
Topics: Acetazolamide; Adolescent; Aphasia; Brain; Brain Edema; Cerebral Angiography; Cerebral Infarction; C | 2010 |
[Impairment of vasoreactivity in brainstem and hemispheral small vessel disease: comparative study].
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Basilar Artery; Blood Flow Velocity; Brain Stem; Carb | 2002 |
Hemodynamic changes during neural deactivation in human brain: a positron emission tomography study of crossed cerebellar diaschisis.
Topics: Acetazolamide; Adult; Aged; Blood Flow Velocity; Brain Mapping; Carbon Dioxide; Cerebellum; Cerebral | 2002 |
The effect of deafferentation on cerebral blood flow response to acetazolamide.
Topics: Acetazolamide; Aged; Blood Volume; Carbonic Anhydrase Inhibitors; Cerebellar Cortex; Cerebral Cortex | 2004 |
Steroid responsive late deterioration in Cryptococcus neoformans variety gattii meningitis.
Topics: Acetazolamide; Adult; Amphotericin B; Antifungal Agents; Arachnoiditis; Cerebral Infarction; Dexamet | 2004 |
Dynamic CT perfusion imaging with acetazolamide challenge for evaluation of patients with unilateral cerebrovascular steno-occlusive disease.
Topics: Acetazolamide; Aged; Aged, 80 and over; Basal Ganglia; Blood Circulation; Blood Flow Velocity; Blood | 2006 |
Cerebral vasomotor reactivity of patients with acute ischemic stroke: Cortical versus subcortical infarcts: an Israeli-Turkish collaborative study.
Topics: Acetazolamide; Aged; Aged, 80 and over; Arterioles; Brain Ischemia; Carbonic Anhydrase Inhibitors; C | 2007 |
Time dependency of the acetazolamide effect on cerebral hemodynamics in patients with chronic occlusive cerebral arteries. Early steal phenomenon demonstrated by [15O]H2O positron emission tomography.
Topics: Acetazolamide; Aged; Arterial Occlusive Diseases; Blood Pressure; Brain Ischemia; Carotid Artery, In | 1995 |
[Cerebral blood flow increase and P300 latency prolongation by intravenous injection of acetazolamide--investigation in lacunar cerebral infarction and healthy subjects].
Topics: Acetazolamide; Adult; Aged; Cerebral Infarction; Cerebrovascular Circulation; Evoked Potentials, Som | 1995 |
P300 and xenon computed tomography before and after intravenous injection of acetazolamide.
Topics: Acetazolamide; Brain; Cerebral Infarction; Cerebrovascular Circulation; Evoked Potentials; Humans; I | 1995 |
A study of acetazolamide-induced changes in cerebral blood flow using 99mTc HMPAO SPECT in patients with cerebrovascular disease.
Topics: Acetazolamide; Adult; Aged; Brain; Brain Mapping; Carotid Artery, Internal; Carotid Stenosis; Cerebr | 1995 |
An approach to cerebral vasodilatory capacity in unilateral and bilateral cerebrovascular diseases using radiolabeled human serum albumin.
Topics: Acetazolamide; Adolescent; Adult; Aged; Carotid Stenosis; Cerebral Infarction; Cerebrovascular Circu | 1995 |
Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography.
Topics: Acetazolamide; Adolescent; Adult; Aged; Blood Flow Velocity; Brain; Brain Ischemia; Cerebral Cortex; | 1995 |
Crossed cerebellar diaschisis and brain recovery after stroke.
Topics: Acetazolamide; Acute Disease; Adult; Aged; Aged, 80 and over; Brain Ischemia; Cerebellum; Cerebral I | 1995 |
Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease.
Topics: Acetazolamide; Adult; Aged; Carotid Stenosis; Cerebral Arteries; Cerebral Infarction; Cerebrovascula | 1995 |
Cerebral vasodilatory capacity mapping using technetium-99m-DTPA-HSA SPECT and acetazolamide in moyamoya disease.
Topics: Acetazolamide; Cerebral Infarction; Cerebrovascular Circulation; Humans; Male; Middle Aged; Moyamoya | 1993 |
Prediction of cerebral infarction due to vasospasm following aneurysmal subarachnoid haemorrhage using acetazolamide-activated 123I-IMP SPECT.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Amphetamines; Aneurysm, Ruptured; Brain; Cerebral Inf | 1993 |
Hypoperfusion and vasoreactivity in the thalamus and cerebellum after stroke.
Topics: Acetazolamide; Aged; Cerebellum; Cerebral Infarction; Female; Humans; Male; Middle Aged; Thalamus; T | 1993 |
Noninvasive measurements of regional cerebral blood flow using technetium-99m hexamethylpropylene amine oxime.
Topics: Acetazolamide; Algorithms; Brain; Cerebral Infarction; Cerebrovascular Circulation; Female; Humans; | 1993 |
Contribution of arterial blood pressure to the clinical expression of lacunar infarction.
Topics: Acetazolamide; Age Factors; Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Brain Ische | 1996 |
Persisting perfusion defect in transient ischemic attacks: a new clinically useful subgroup?
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Brain; Carotid Arteries; Cerebral Infarction; Cerebro | 1996 |
Cerebellar vascular response to acetazolamide in crossed cerebellar diaschisis: a comparison of 99mTc-HMPAO single-photon emission tomography with 15O-H2O positron emission tomography.
Topics: Acetazolamide; Adult; Aged; Cerebellum; Cerebral Infarction; Cerebrovascular Circulation; Female; Hu | 1996 |
Brain SPECT with dipyridamole stress to evaluate cerebral blood flow reserve in carotid artery disease.
Topics: Acetazolamide; Aged; Brain; Brain Ischemia; Carotid Artery, Internal; Carotid Stenosis; Cerebral Inf | 1996 |
Dissociation of vasoreactivity to acetazolamide and hypercapnia. Comparative study in patients with chronic occlusive major cerebral artery disease.
Topics: Acetazolamide; Aged; Carbonic Anhydrase Inhibitors; Cerebral Infarction; Cerebrovascular Circulation | 1996 |
Magnetic resonance imaging quantitation of superior sagittal sinus flow: correlation to cerebral blood flow measured by xenon-enhanced computed tomography.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Artifacts; Brain; Brain Neoplasms; Cerebral Hemorrhag | 1997 |
Cerebral blood flow in single and multiple lacunar infarctions.
Topics: Acetazolamide; Alcoholism; Cerebral Infarction; Cerebrovascular Circulation; Diabetes Complications; | 1997 |
Hemodynamic aspect of cerebral watershed infarction: assessment of perfusion reserve using iodine-123-iodoamphetamine SPECT.
Topics: Acetazolamide; Amphetamines; Angiography, Digital Subtraction; Brain; Case-Control Studies; Cerebral | 1997 |
Blood flow differences between leuko-araiosis with and without lacunar infarction.
Topics: Acetazolamide; Aged; Brain; Cerebral Infarction; Cerebrovascular Circulation; Female; Humans; Inject | 1998 |
[A study on accuracy of rCBF measurements loaded with acetazolamide based on the microsphere model using iodine-123-IMP SPECT].
Topics: Acetazolamide; Adult; Amphetamines; Brain; Cerebral Infarction; Cerebrovascular Circulation; Female; | 1998 |
Impaired cerebrovascular reactivity as a risk marker for first-ever lacunar infarction: A case-control study.
Topics: Acetazolamide; Arterioles; Blood Flow Velocity; Carbonic Anhydrase Inhibitors; Case-Control Studies; | 1999 |
Single lacunar brain infarction with transient signs versus those with long-lasting signs.
Topics: Acetazolamide; Aged; beta-Thromboglobulin; Biomarkers; Carbonic Anhydrase Inhibitors; Cerebral Infar | 1999 |
Acetazolamide reactivity in atherothrombotic, cardioembolic and lacunar infarctions.
Topics: Acetazolamide; Aged; Case-Control Studies; Cerebral Infarction; Cerebrovascular Circulation; Female; | 2000 |
Effects of bunazosin hydrochloride sustained-release formulation on cerebral circulation.
Topics: Acetazolamide; Adrenergic alpha-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood F | 2000 |
CBF side-to-side asymmetries in stenosis-occlusion of internal carotid artery. Relevance of CT findings and collateral supply.
Topics: Acetazolamide; Adult; Aged; Carotid Artery, Internal; Carotid Stenosis; Cerebral Infarction; Cerebro | 1991 |
[A fundamental study of Diamox load scintigraphy using 99mTc-HM-PAO].
Topics: Acetazolamide; Adolescent; Adult; Aged; Brain; Brain Ischemia; Cerebral Infarction; Cerebrovascular | 1991 |
SPECT analysis of recent cerebral infarction.
Topics: Acetazolamide; Aged; Amphetamines; Cerebral Infarction; Cerebrovascular Circulation; Female; Humans; | 1989 |
Tomographic cerebral blood flow measurements in patients with ischemic cerebrovascular disease and evaluation of the vasodilatory capacity by the acetazolamide test.
Topics: Acetazolamide; Aminophylline; Blood Flow Velocity; Brain Ischemia; Carotid Artery Diseases; Cerebral | 1988 |